Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul Study

Carmen A Peralta1, Mary A Whooley, Joachim H Ix

  • 1General Internal Medicine Section, San Francisco Veterans Affairs Medical Center, and Department of Medicine, University of California, San Francisco, San Francisco, California 94124, USA. carmenalicia.peralta@ucsf.edu

Insights

Systolic blood pressure and pulse pressure are linked to kidney function across a broad range, even in those with normal kidney function. Cystatin C offers new insights into hypertension control in chronic kidney disease (CKD).

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Hypertension control is critical for managing chronic kidney disease (CKD).
  • Previous studies explored kidney function and blood pressure (BP) in diagnosed CKD, diabetes, or hypertension.
  • The association between normal kidney function and BP components remains unclear.

Purpose of the Study:

  • To investigate the relationship between kidney function and systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure.
  • To evaluate kidney function using cystatin C and 24-hour creatinine clearance (CrCl).

Main Methods:

  • Utilized data from 906 participants in the Heart and Soul Study.
  • Assessed kidney function via cystatin C and 24-hour creatinine clearance (CrCl).
  • Analyzed associations between kidney function markers and BP components (SBP, DBP, pulse pressure).

Main Results:

  • SBP showed a linear association with cystatin C across all kidney function levels.
  • SBP was significantly linked to kidney function (CrCl<60 mL/min) but not in those with CrCl>60 mL/min.
  • Diastolic blood pressure (DBP) was not associated with cystatin C or CrCl.
  • Pulse pressure linearly correlated with cystatin C and with CrCl<60 mL/min.

Conclusions:

  • Both SBP and pulse pressure are significantly associated with kidney function across a wide range of cystatin C levels.
  • These associations hold true even in individuals with seemingly normal kidney function by creatinine-based measures.
  • Cystatin C may offer novel perspectives on the CKD-hypertension link, potentially highlighting an overlooked barrier to BP management.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Introduction to Urinary System01:13

Introduction to Urinary System

The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...